US2016023998A1PendingUtilityA1

Hydrolysable linkers and cross-linkers for absorbable polymers

Assignee: BEZWADA BIOMEDICAL LLCPriority: Sep 17, 2007Filed: Oct 6, 2015Published: Jan 28, 2016
Est. expirySep 17, 2027(~1.2 yrs left)· nominal 20-yr term from priority
Inventors:Rao S. Bezwada
C07C 265/12C07C 235/16C07C 69/34C07C 225/22Y10T24/51C07C 205/37C07C 69/67A61L 17/12A47F 5/0006Y10T428/139C07C 205/57Y10T24/44291A61L 24/06A61L 31/145A61L 17/105B65D 25/22Y02W90/10A61L 27/34A61L 17/145C07C 217/84C07C 219/34C08G 63/16C07C 229/18C08G 63/916C07C 69/708A61L 27/52A61L 31/10A61L 31/148Y10T442/10A61L 17/00A61L 27/18C07C 205/43C07C 229/60A61L 27/58
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to the discovery of new class of linear and multiarmed hydrolysable linkers and cross linkers for use in the synthesis of biodegradable polymers such as, polyesters, polyurethanes, polyamides, polyureas and degradable epoxy amine resin. The linear and multiarmed hydrolysable linkers of the present invention include symmetrical and/or unsymmetrical ether carboxylic acids, amines, amide diols, amine polyols and isocyanates.

Claims

exact text as granted — not AI-modified
1 . A compound of Formula C, XIII, XIV, XV, or XVI: 
       
         
           
           
               
               
           
         
       
       wherein: 
       R is independently a C 1-25  alkylene diradical, wherein from 1-4 of the CH 2  groups within the alkyl chain are optionally independently replaced by O or S atoms, such that each of said O or S atoms is attached only to carbon atoms in the alkyl chain, with the proviso that multiple heteroatoms must be separated from each other and from the diradical chain ends by at least one carbon atom; 
       each a is independently an integer from 1 to 6; 
       alternatively, in formula XIII, XIV, XV, or XVI, each a is independently 0; 
       each b is independently an integer from 1 to 6; 
       each X is independently:
 —OC(═O)CH 2 — (inverse glycolic acid moiety), 
 —OC(═O)CH(CH 3 )— (inverse lactic acid moiety), 
 —OC(═O)CH 2 OCH 2 CH 2 — (inverse dioxanone acid moiety), 
 —OC(═O)CH 2 CH 2 CH 2 CH 2 CH 2 — (inverse caprolactone acid moiety), 
 —OC(═O)(CH 2 ) y —, or 
 —OC(═O)CH 2 (OCH 2 CH 2 ) z —; 
 
       each X 1  is independently:
 —CH 2 C(═O)O— (glycolic acid moiety), 
 —CH(CH 3 )C(═O)O— (lactic acid moiety), 
 —CH 2 CH 2 OCH 2 C(═O)O— (dioxanone acid moiety), 
 —CH 2 CH 2 CH 2 CH 2 CH 2 C(═O)O— (caprolactone acid moiety), 
 —(CH 2 ) y C(═O)O—, or 
 —(CH 2 CH 2 O) z CH 2 C(═O)O—; 
 
       each Y is independently:
 —OCH 2 C(═O)— (inverse glycolic ester moiety), 
 —OCH(CH 3 )C(═O)— (inverse lactic ester moiety), 
 —OCH 2 CH 2 OCH 2 C(═O)— (inverse dioxanone ester moiety), 
 —OCH 2 CH 2 CH 2 CH 2 CH 2 C(═O)— (inverse caprolactone ester moiety), 
 —O(CH 2 ) m C(═O)—, or 
 —O(CH 2 CH 2 O) n OCH 2 C(═O)—; 
 
       each Y 1  is independently:
 —C(═O)CH 2 O— (glycolic ester moiety), 
 —C(═O)CH(CH 3 )O— (lactic ester moiety), 
 —C(═O)CH 2 OCH 2 CH 2 O— (dioxanone ester moiety), 
 —C(═O)CH 2 CH 2 CH 2 CH 2 CH 2 O— (caprolactone ester moiety), 
 —C(═O)(CH 2 ) m O—, or 
 —C(═O)CH 2 O(CH 2 CH 2 O) n —; and 
 
       each m and n is independently an integer selected from 2 to 24. 
     
     
         2 . The compound of  claim 1 ,
 wherein:   
       each X is independently:
 —OC(═O)CH 2 —, —OC(═O)CH(CH 3 )—, —OC(═O)CH 2 OCH 2 CH 2 —, 
 
       or —OC(═O)CH 2 CH 2 CH 2 CH 2 CH 2 —; 
       each X 1  is independently:
 —CH 2 C(═O)O—, —CH(CH 3 )C(═O)O—, —CH 2 CH 2 OCH 2 C(═O)O—, 
 
       or —CH 2 CH 2 CH 2 CH 2 CH 2 C(═O)O—, 
       each Y is independently: —OCH 2 C(═O)—, —OCH(CH 3 )C(═O)—, —OCH 2 CH 2 OCH 2 C(═O)—, or —OCH 2 CH 2 CH 2 CH 2 CH 2 C(═O)— 
       each Y 1  is independently: —C(═O)CH 2 O—, —C(═O)CH(CH 3 )O—, —C(═O)CH 2 OCH 2 CH 2 O—, or —C(═O)CH 2 CH 2 CH 2 CH 2 CH 2 O—. 
     
     
         3 . The compound of  claim 2 ,
 wherein:   
       each X is independently: —OC(═O)CH 2 — or —OC(═O)CH(CH 3 )—; 
       each X 1  is independently: —CH 2 C(═O)O— or —CH(CH 3 )C(═O)O—; 
       each Y is independently: —OCH 2 C(═O)— or —OCH(CH 3 )C(═O)—; 
       each Y 1  is independently: —C(═O)CH 2 O— or —C(═O)CH(CH 3 )O—. 
     
     
         4 . The compound of  claim 1 , wherein the compound is a diacid of the structure: 
       
         
           
           
               
               
           
         
       
     
     
         5 . The compound of  claim 1 , wherein the compound is a diacid of the structure: 
       
         
           
           
               
               
           
         
       
     
     
         6 . The compound of  claim 1 , wherein the compound is a diacid of the structure: 
       
         
           
           
               
               
           
         
       
     
     
         7 . The compound of  claim 1 , wherein the compound is of the structure: 
       
         
           
           
               
               
           
         
       
     
     
         8 . The compound of  claim 1 , wherein the compound is of the structure: 
       
         
           
           
               
               
           
         
       
     
     
         9 . The compound of  claim 1 , wherein the compound is a diisocyanate of the structure:

Join the waitlist — get patent alerts

Track US2016023998A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.